Menu
Enrolling by invitation NCT07313956

Mode of Ventilation During Critical Illness at Multiple Centers

No phase Interventional Respiratory Failure Mechanical Ventilation Critical Illness

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Volume control, Pressure control, Adaptive pressure control.
Who it may be relevant to
Registry conditions: Respiratory Failure, Mechanical Ventilation, Critical Illness. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this clinical trial is to learn whether the choice of ventilator mode for patients on breathing machines in the intensive care unit affects their survival and recovery. To do this, researchers will assign the entire participating intensive care unit to one of the three available ventilator modes, alternating which mode is assigned in random sequence every 2 months. The main question it aims to answer is: Does the choice between volume control, pressure control, and adaptive pressure control affect the number of days that patients are alive and free of the breathing machine?

Detailed description

The MODEM trial is a cluster-randomized, cluster-crossover clinical trial comparing the effectiveness of three ventilator modes (volume control vs pressure control vs adaptive pressure control) for mechanical ventilation of critically ill adults at multiple centers. A total of 4,785 critically ill adults receiving invasive mechanical ventilation in intensive care units will be enrolled and included in the primary analysis. Each study unit will be assigned to a ventilator mode and will switch between modes every 2 months in an order determined by randomization. Enrolled patients will be assigned to receive volume control, pressure control, or adaptive pressure control according to the mode assigned to the unit at the time they were enrolled. The primary outcome will be ventilator-free days in the first 28 days, and the secondary outcome will be all-cause, 28-day in-hospital mortality.

Interventions

  • Other Volume control
    Volume control mode for invasive mechanical ventilation
  • Other Pressure control
    Pressure control mode for invasive mechanical ventilation
  • Other Adaptive pressure control
    Adaptive pressure control for invasive mechanical ventilation

Primary outcome measures

  • Ventilator-free days in the first 28 days [Time frame: From enrollment to 28 days after enrollment]
Secondary outcome measures (1)
  • All-cause, 28-day, in-hospital mortality [Time frame: From enrollment to 28 days after enrollment]

Eligibility criteria

Inclusion criteria

  • Patient is receiving mechanical ventilation through an endotracheal tube or tracheostomy
  • Patient is physically located in a participating adult ICU

Exclusion criteria

  • Patient is known to be less than 18 years old
  • Patient is known to be a prisoner
  • Patient is known to have been receiving invasive mechanical ventilation at place of residence prior to hospital admission
  • Patient is receiving extracorporeal membrane oxygenation at the time when inclusion criteria are first met

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 4 centers
  • Rush University Medical Center — Chicago
  • The Johns Hopkins Hospital — Baltimore
  • Wake Forest University Health Sciences — Winston-Salem
  • Vanderbilt University Medical Center — Nashville

Publications

  • Rappaport SH, Shpiner R, Yoshihara G, Wright J, Chang P, Abraham E. Randomized, prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure. Crit Care Med. 1994 Jan;22(1):22-32. doi: 10.1097/00003246-199401000-00009. PMID 8124968
  • Esteban A, Alia I, Gordo F, de Pablo R, Suarez J, Gonzalez G, Blanco J. Prospective randomized trial comparing pressure-controlled ventilation and volume-controlled ventilation in ARDS. For the Spanish Lung Failure Collaborative Group. Chest. 2000 Jun;117(6):1690-6. doi: 10.1378/chest.117.6.1690. PMID 10858404
  • Rittayamai N, Katsios CM, Beloncle F, Friedrich JO, Mancebo J, Brochard L. Pressure-Controlled vs Volume-Controlled Ventilation in Acute Respiratory Failure: A Physiology-Based Narrative and Systematic Review. Chest. 2015 Aug;148(2):340-355. doi: 10.1378/chest.14-3169. PMID 25927671
  • Chatburn RL, El-Khatib M, Mireles-Cabodevila E. A taxonomy for mechanical ventilation: 10 fundamental maxims. Respir Care. 2014 Nov;59(11):1747-63. doi: 10.4187/respcare.03057. Epub 2014 Aug 12. PMID 25118309
  • Telias I, Madorno M, Pham T, Coudroy R, Mellado Artigas R, Baedorf-Kassis E, Chen CW, Spadaro S, Chiumello D, Beitler J, Kondili E, Tiribelli N, Fredes S, Becher T, Dres M, Liu K, Terzi N, Guerin C, Mauri T, Roca O, Mancebo J, Rodriguez N, Arnal JM, Goligher EC, Diehl JL, Jochmans S, Beloncle F, Rittayamai N, Mojoli F, Heunks L, de Vries H, Zhou JX, Guervilly C, Brochard L; BEARDS and PLUG Investi PMID 40700741
  • Seitz KP, Lloyd BD, Wang L, Shotwell MS, Qian ET, Muhs AL, Richardson RK, Rooks JC, Hennings-Williams V, Sandoval CE, Richardson WD, Morgan TL, Thompson AN, Hastings PG, Ring TP, Stollings JL, Talbot EM, Krasinski DJ, DeCoursey BR, Marvi TK, DeMasi SC, Gibbs KW, Self WH, Mixon AS, Rice TW, Semler MW, Casey JD; Pragmatic Critical Care Research Group. Effect of Ventilator Mode on Ventilator-Free Day PMID 40189043

Identifiers

NCT: NCT07313956 · 250596 · K23HL175246

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗